An external advisory board (EAB) consisting of both researchers and the users of research provides external guidance which complements the expertise of the Center researchers. The EAB members will: 1) review study implementation; 2) provide technical assistance on design, implementation, analysis, and interpretation of the studies; 3) review study findings and implications; 4) advise on dissemination of results into the real world of drug abuse service delivery; and 5) advise on research direction and collaboration with other institutions.
Despite many advances in research, study findings are not making the intended impact of improving drug abuse service delivery in this country. In support of the great need and value in enhancing the collaborative relationship between the research community and other stakeholders in substance abuse service delivery, the EAB not only includes prominent representatives of the substance abuse research community, but also represents the perspectives of other stakeholders in the delivery of services in a managed care environment: providers, payers, managed care organizations, community groups, and communications experts. The EAB's goal will be to increase the likelihood that rigorous research findings have practical application in service delivery and are shared outside the research arena.
External Advisory Board members are:
- Laura Altman, Ph.D.
Principal, Towers Perrin (retired) - Michael Botticelli, M.Ed., Assistant Commissioner for Substance Abuse Services at the Massachusetts Department of Public Health
- Simon Budman, Ph.D., President and CEO
Inflexxion, Inc. - John Daigle, Executive Director
Florida Alcohol and Drug Abuse Association (FADAA) - Bruce Davidson, Vice President of Operations
Corporate Counseling Associates, Inc. - Lewis Gallant, Ph.D., Executive Director
National Association of State Alcohol and Drug Abuse Directors (NASADAD) - Steve Gallon, Ph.D., Project Director
Northwest Frontier Addiction Technology Transfer Center (ATTC)
Oregon Health Sciences University - David Gastfriend, M.D., Vice President, Medical Affairs
Alkermes, Inc. - Eric Goplerud, Ph.D., Research Professor
Department of Health Policy, George Washington University - Janice Ford Griffin, Deputy Director
Join Together and leader of Demand Treatment Initiative - David Gustafson, Ph.D., Research Professor
University of Wisconsin/Madison and National Program Director
Network for the Improvement of Addiction Treatment - Cirilo Madrid, Executive Director
Alivane No-Ad, Inc. - Kathryn Magruder, M.P.H, Ph.D., Associate Professor
Department of Psychiatry and Behavioral Sciences
Medical University of South Carolina and Director of Health Care Research - Frank McCorry, Ph.D., Director
Clinical Services Unit, New York State Office of Alcoholism and
Substance Abuse Services - Thomas McLellan, Ph.D., Scientific Director
Treatment Research Institute - Elizabeth Pattullo, President and CEO
Beacon Health Strategies - Rhonda Robinson-Beale, M.D., Senior Vice President and Chief Medical Officer
Cigna Behavioral Health - David Rosenbloom, Ph.D., Director
Join Together - Jochaim Roski, Ph.D., M.P.H., Associate Vice President for Quality Measurement
National Committee for Quality Assurance (NCQA) - Leif Solberg, M.D., Associate Medical Director
Care Improvement Research, Health Partners - Constance Weisner, Dr.P.H., Professor, Department of Psychiatry
University of California - San Francisco and Northern California Division of Research, Kaiser Permanente